As of 2:31 PM on the 19th, Celltrion Healthcare is trading at 134,400 KRW, down 1.18% from the previous day. This marks a 14.67% decrease compared to February 1st. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.

Today, foreigners have a net purchase of 25,000 shares of Celltrion Healthcare, while institutions have a net sale of 1,000 shares, according to provisional data. Over the past five days, individual investors have net purchased 243,267 shares, whereas foreigners and institutions have net sold 109,486 shares and 145,271 shares, respectively.





[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing